Y-Intercept (HK)’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
+7,682
| New | +$2.94M | 0.07% | 431 |
|
|
2025
Q1 | – | Sell |
-18,587
| Closed | -$5.58M | – | 1364 |
|
|
2024
Q4 | $5.58M | Buy |
18,587
+12,571
| +209% | +$3.77M | 0.37% | 35 |
|
|
2024
Q3 | $2.45M | Sell |
6,016
-4,727
| -44% | -$1.92M | 0.15% | 163 |
|
|
2024
Q2 | $3.45M | Buy |
+10,743
| New | +$3.45M | 0.19% | 110 |
|
|
2024
Q1 | – | Sell |
-816
| Closed | -$221K | – | 1528 |
|
|
2023
Q4 | $221K | Sell |
816
-10,024
| -92% | -$2.71M | 0.02% | 963 |
|
|
2023
Q3 | $2.67M | Buy |
10,840
+325
| +3% | +$79.9K | 0.26% | 87 |
|
|
2023
Q2 | $3.19M | Buy |
10,515
+908
| +9% | +$276K | 0.34% | 45 |
|
|
2023
Q1 | $2.53M | Buy |
9,607
+6,475
| +207% | +$1.71M | 0.29% | 53 |
|
|
2022
Q4 | $752K | Sell |
3,132
-17,788
| -85% | -$4.27M | 0.11% | 288 |
|
|
2022
Q3 | $3.84M | Sell |
20,920
-17,015
| -45% | -$3.13M | 0.38% | 37 |
|
|
2022
Q2 | $6.38M | Buy |
+37,935
| New | +$6.38M | 0.84% | 6 |
|
|
2022
Q1 | – | Sell |
-15,772
| Closed | -$4.05M | – | 812 |
|
|
2021
Q4 | $4.05M | Buy |
15,772
+6,854
| +77% | +$1.76M | 0.96% | 9 |
|
|
2021
Q3 | $2.17M | Buy |
8,918
+7,624
| +589% | +$1.85M | 0.39% | 52 |
|
|
2021
Q2 | $268K | Buy |
+1,294
| New | +$268K | 0.07% | 443 |
|